Navigation Links
Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
Date:2/5/2008

hat can control gene expression and, consequently, cell function. Sangamo is also developing sequence-specific ZFP Nucleases (ZFN(TM)) for gene modification. Sangamo has established strategic partnerships with companies outside of the human therapeutic space including Dow AgroSciences, Sigma-Aldrich Corporation and several companies applying its ZFP Technology to enhance the production of protein pharmaceuticals. For more information about Sangamo, visit the company's web site at http://www.sangamo.com.

This press release contains forward-looking statements regarding Sangamo's current expectations. These forward looking statements include, without limitation, references to the research and development of ZFP TFs and ZFNs, clinical trials and therapeutic applications of Sangamo's ZFP technology platform, achievement of research milestones and objectives, strategic partnership with collaborators and anticipated amount of cash and cash equivalents. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, the early stage of ZFP Therapeutic development, uncertainties related to the timing of initiation and completion of clinical trials, whether clinical trial results will validate and support the safety and efficacy of ZFP Therapeutics, and the ability to establish strategic partnerships. Further, there can be no assurance that the necessary regulatory approvals will be obtained or that Sangamo will be able to develop commercially viable gene based therapeutics. Actual results may differ from those projected in forward-looking statements due to risks and uncertainties that exist in the company's operations and business environments. These risks and uncertainties are described more fully in the company's' Annual Reports on Form 10-K and Qu
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
2. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
3. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
4. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
5. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
6. Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis
7. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
8. Epiphany Biosciences Reports Initiation and Enrollment in Valomaciclovir Study for Shingles
9. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
10. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
11. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014 Professional Compounding ... paediatric medicine by awarding the three best scientific ... initiative (EuPFI) conference . The Formulating Better ... 18 in Athens, Greece , ... students and professionals, from which three winners will ...
(Date:8/21/2014)... 2014 Asterias Biotherapeutics, Inc. (OTCBB: ASTY), a ... medicine, announced today the appointments of Andrew ("Andy") Arno ... Board of Directors. With these additions, the Asterias Board ... are independent. Andy Arno , 55, ... companies. He is currently Managing Director of Emerging Growth ...
(Date:8/20/2014)... LUTHERVILLE, Md. , Aug. 20, 2014 /PRNewswire/ ... (NADDI) today lauded the latest results achieved by ... system, known as the National Precursor Log Exchange ... law enforcement officials track down meth offenders and ... technology in Kansas blocked ...
Breaking Medicine Technology:Professional Compounding Centers of America will award top poster-session winners at European Paediatric Formulation Initiative in Athens 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 4Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
(Date:8/21/2014)... HealthDay Reporter THURSDAY, Aug. 21, 2014 (HealthDay ... nearly 12 percent in the last decade, a new report ... teens using indoor tanning beds barely decreased. Both indoor tanning ... cancers, including deadly melanomas, the researchers noted. "Unfortunately, we ... reported wearing sunscreen, from 67.7 percent in 2001 to 56.1 ...
(Date:8/21/2014)... Orange, NJ. August 21, 2014. Researchers have published ... the outcomes of patients with motor complete spinal ... disparities in functioning at discharge and follow-up among ... ahead of print on August 2 by the ... (doi: 10.1016/j.apmr.2014.07.398). Findings included small but significant differences ...
(Date:8/21/2014)... 2014 CarePoint Health is proud ... Patel, MD, and Sujoy Menon, MD, have joined ... and Dr. Menon to the community. CarePoint Health’s ... imaging services to patients in Hudson County through ... Hospital and Hoboken University Medical Center. Our board ...
(Date:8/21/2014)... August 21, 2014 The Mount Sinai ... tool called RateMyHospital®, which captures real-time patient feedback and ... patient’s care. The tool, now available to admitted patients ... collects feedback regarding patient satisfaction using smartphones. , ... because it gives us the timely information we need ...
(Date:8/21/2014)... New York (PRWEB) August 21, 2014 ... Cannabis Network that a company located in Massachusetts has ... the only marijuana patient verification system in ... welcome this new entity to our growing and compassionate ... our belief that these claims are inaccurate. , ...
Breaking Medicine News(10 mins):Health News:Fewer U.S. Teens Using Sunscreen, Study Finds 2Health News:Researchers examine impact of race and ethnicity in motor complete spinal cord injury 2Health News:Two Top Radiologists Join CarePoint Health 2Health News:The Mount Sinai Hospital Expands Use of Mobile Patient Satisfaction Tool 2Health News:The Mount Sinai Hospital Expands Use of Mobile Patient Satisfaction Tool 3Health News:MarijuanaDoctors.com Responds to Massachusetts Company's Claim 2
... TOWNSHIP, Mich., Jan. 27 Financing has become a,very popular ... decade.,But long after you have had your "nip and tuck", ... looking for ways to get out of debt, and at ... surgery. , Dr. Charles Mok ...
... system chosen needs to match needs, culture of staff , , ... hospital is, the lower its rate of patient deaths and ... also saves centers money, the researchers report. , Although there ... Herrick, senior fellow at the National Center for Policy Analysis ...
... for the prevention of coronary heart disease, with ... at highest risk (ie, those with established heart ... estimation models may not be accurately achieved in ... groups whose 10-year "short-term" estimated risk seems low. ...
... Participants Control Weight Permanently , MIDLAND, Mich., Jan. 27 ... term is the challenge. With this Health Enhancement Systems ... NutriSum: Healthy Weight for Life ( ... to gain control of their weight -- and improve their ...
... Create SolutionsPITTSBURGH, Jan. 27 To ... and consultants, HM Insurance Group, a Highmark company, ... product line, which features dedicated worksite sales specialists, ... and membership management in a highly coordinated approach ...
... One in eight physicians have been inactive in the ... and most states do not require them to undergo competency ... , Because of the lack of regulation, patient safety could ... of Michigan Child Health Evaluation and Research (CHEAR) Unit and ...
Cached Medicine News:Health News:Lay Away Plan for Cosmetic Surgery 2Health News:'Wired' Hospitals Post Lower Death, Complication Rates 2Health News:'Wired' Hospitals Post Lower Death, Complication Rates 3Health News:Assessing the real risk of heart disease in young people with low short-term risks 2Health News:Thousands Look Better, Feel Better, and Have More Energy Because of NutriSum 2Health News:HM Insurance Group Launches Next Generation Worksite Product Line 2Health News:HM Insurance Group Launches Next Generation Worksite Product Line 3Health News:Most inactive physicians retain licenses, return to practice without competency review 2
Lumbar Allograft with Osteoactive advantage. Promotes bone formation and faster incorporation. Derived from the proven technology behind Grafton DBM. Maintains structural integrity and strength....
Williams Micro Discectomy Instruments are designed to be used in the microsurgical treatment of herniated disks....
... System offers strength and radiolucent capabilities ... anteater titanium microdiscectomy system for microscope-aided ... for less invasive procedures with reduced ... to provide low profile, unobstructed retraction ...
Poppen-Gelpi Laminectomy Retractor, self-retaining....
Medicine Products: